The largest database of trusted experimental protocols

Anti gm csf

Manufactured by R&D Systems
Sourced in United States

Anti-GM-CSF is a laboratory reagent that can be used to detect and quantify granulocyte-macrophage colony-stimulating factor (GM-CSF) in various sample types. It is a neutralizing antibody that binds to GM-CSF, a cytokine that plays a role in the regulation of white blood cell production and function. Anti-GM-CSF can be used in a variety of immunoassay techniques to measure GM-CSF levels.

Automatically generated - may contain errors

8 protocols using anti gm csf

1

Investigating T Cell Responses to GM-CSF and CXCL11

Check if the same lab product or an alternative is used in the 5 most similar protocols
To examine the effects of GM-CSF, CXCL11 and their blockade on T cell responses, human monocytes and naïve T cells were isolated from peripheral blood of healthy volunteers by magnetic cell isolation according to the company’s instructions (Miltenyi Biotec). Purified monocytes at 2 × 104 were seeded to U bottom 96 well plates and cultured in IMDM culture medium, which contained 10% FBS and 1% penicillin-streptomycin, in 7 groups with different treatment conditions including PBS, GM-CSF (10 ng/ml), Anti-GM-CSF (10 µg/ml), RHCXCL11(15 ng/ml) (R&D Systems), RHCXCL11 + GM-CSF, Anti CXCL11 (10 µg/ml) (R&D Systems, USA), and Anti-GM-CSF + Anti-CXCL11 for 24 hours. The following day, isolated naïve T cells were labeled with Cell Trace Violet (Thermo Fisher) following the manufacturer’s instructions. T cells were then stimulated with the soluble anti-CD3 antibody at a concentration of 1 µg/ml. T cells were then added (1 × 105 cells per well) to the same monocyte wells for cell-cell interactions and kept humidified in a 5% CO2 incubator at 37 °C for 72 hours. After that time, cell culture supernatant was carefully removed and immediately frozen at −20 °C. To measure the proliferative capacity of T cells, CFSE intensity in the cells was assessed by flow cytometry.
+ Open protocol
+ Expand
2

Cytokine Regulation of CD4+ T Cell

Check if the same lab product or an alternative is used in the 5 most similar protocols
CD4+CCR6+CXCR3- T cells were separated by cell sorting; CD11C+ APCs were separated using a CD11C positive selection kit (STEMCELL). Sorted CD4+CCR6+ CXCR3- T cells and CD11C+ APCs were co-cultured at a ratio of 2:1 with or without anti-GM-CSF (10 µg/mL; R&D Systems) or IL-38(10 ng/mL) for 24 hours. IL-23 levels in the supernatants were measured using mouse IL-23 ELISA kit (Thermo Fisher Scientific).
+ Open protocol
+ Expand
3

GIFT4 Signaling and B-cell Activation

Check if the same lab product or an alternative is used in the 5 most similar protocols
GIFT4, GM-CSF, IL-4 and IFN-γ were quantified with ELISA kits (eBiosciences, San Diego, CA). GIFT4 were profiled by Western blot (WB) with anti-GM-CSF or anti-IL-4 antibodies (R&D systems). Murine B-cells (106 cells/ml) treated with GIFT4, GM-CSF and IL-4 with or without JAK inhibitors were lysed with buffer as described (21 (link)). STAT phosphorylation in B-cells was determined by WB with anti-pSTAT1 (Tyr701, D4A7), anti-pSTAT3 (Tyr705, D3A7), anti-pSTAT5 (Tyr694, D47E7), anti-pSTAT6 (Tyr641, C11A12), or anti-STAT antibodies (Cell Signaling). For immunoprecipitation of GMCSFRβ by common γc receptor after GIFT4 or GM-CSF and IL-4 stimulation, the B-cells were lysed with buffer as described (21 (link)). One mg of protein per sample was incubated with 2 mg of anti-common γc or anti-GMCSFR antibodies, or IgG isotype control (Santa Cruz Biotechnology, CA) overnight at 4°C. The sample-antibody complexes were incubated with protein A agarose for 2 hour at 4°C. The bound proteins were eluted for WB with anti-GMCSFR or anti-IL4R antibodies.
+ Open protocol
+ Expand
4

Multiparameter Flow Cytometry Panel

Check if the same lab product or an alternative is used in the 5 most similar protocols
The following antibodies and cell tracer were used staining for flow analysis: FITC-conjugated anti-CD158b (BD Biosciences, San Jose, CA), anti-IFN-γ (eBioscience, San Diego, CA); CFSE; PE-conjugated anti-IFN-γ (BD Biosciences, San Jose, CA), anti-TNF-α, anti-IL-22, anti-granzyme B (eBioscience, San Diego, CA), anti-GM-CSF (R&D Systems, Minneapolis, MN); PerCP-conjugated anti-CD3 (BD Biosciences, San Jose, CA); APC-conjugated anti-CD158a (Miltenyi Biotec, Bergisch Gladbach, Germany), anti-CD4 (BD Biosciences, San Jose, CA), anti-IL-17A (eiBoscience, San Diego, CA); strepavidin-PerCP; PE-Cy7-conjugated anti-CD56, anti-CD14 (BD Biosciences, San Jose, CA), Vioblue-conjugated anti-3DL1 (Miltenyi Biotec, Bergisch Gladbach, Germany), eFluor 650NC-conjugated anti-CD3 (ebBioscience, San Diego, CA). anti-mouse IgG κ/Negative Control Compensation Particles. The use of antibody for staining was performed per manufacturer’s instructions with proper titrations. Antibodies used for cytokine assays are IL-2, IL-6, IL-10, IL-15, IL-13, CCL-4 (MIP-1β), CCL-5, CXCL-10, CCL-2, CXCL-8, IFN-γ, TNF-α, TNF-β, granzyme B, TGF-β1 (R&D Systems, Minneapolis, MN), IL-4, IL-12, GM-CSF, and perforin (eBioscience, San Diego, CA).
+ Open protocol
+ Expand
5

Th17 Cells and APC Interaction

Check if the same lab product or an alternative is used in the 5 most similar protocols
CD4+CCR6+CXCR3 T cells (Th17 cells) were isolated by cell sorting and CD11C+ APCs were isolated by CD11C positive selection kit (STEMCELL, Vancouver, Canada). Then, sorted CD4+CCR6+CXCR3 T cells and CD11C+ APCs were co-cultured at a ratio of 2:1 with or without anti-GM-CSF (10  g/mL, R&D Systems) for 24 h. The supernatants were used to measure IL-23 by ELISA kit (Invitrogen, Carlsbad, CA, USA).
+ Open protocol
+ Expand
6

Monocyte Viability Assay with Cytokines

Check if the same lab product or an alternative is used in the 5 most similar protocols
After thawing, CD14+ monocytes were counted and resuspended in αMEM medium supplemented with 20% FBS. In a 96-well plate, we added 50 μL of cells in each well (45,000 cells/well) and then 50 μL of M-CSF, IL-34, and GM-CSF (all from R&D systems) diluted in 2% RPMI to obtain a 25, 50, and 10 ng/mL final concentration, respectively, or 50 μL of RA SF conditioned media. Medium (50 μL; 2% FBS) without any cytokine was used as control condition (CT). After 3 days, cell viability was assessed by WST-1 cell proliferation Reagent (Roche, France) by adding 10 μL per well. The formazan dye obtained from WST-1 cleavage by mitochondrial dehydrogenase was read by a microplate reader Wallac 1420 Victor 2 (Perkin Elmer, USA) between 420 and 480 nm after incubation for 4 hours at 37°C. Antibodies used to identify cytokines implicated in monocyte viability were as follows: anti M-CSF (R&D Systems), anti-IL-34 (Diaclone, INSERM UMR957), and anti-GM-CSF (R&D Systems) at 2, 10, and 5 μg/mL, respectively. We have previously tested different antibody concentrations to determine the most appropriate concentrations.
+ Open protocol
+ Expand
7

Neutrophil and CD8+ T Cell Migration Assays

Check if the same lab product or an alternative is used in the 5 most similar protocols
Migration of neutrophils, isolated from PBMC of HDs by magnetic beads (EasyStep enrichment kit, StemCell Technologies), was assessed in transwell plates (5 µm pore size, Corning Costar), towards Th17 supernatants or recombinant cytokines (IL-17, R&D Systems, 50 ng/mL; IL-8, R&D Systems, 100 ng/mL; GM-CSF, R&D Systems, 100 ng/mL), for 90 min at 37°C. In specific experiments, anti-IL-8 or anti-GM-CSF antibodies (10 μg/mL, R&D Systems) were added to Th17 supernatants.
Migration of CD8+ T cells, sorted from PBMC of HDs by magnetic microbeads (Miltenyi Biotec) and pre-activated overnight with anti-CD3/CD28 antibodies, was evaluated in transwell plates (5 µm pore size) towards Th17 supernatants, supernatants of HMEC cells, untreated, or exposed overnight to Th17 supernatants or recombinant proteins (IL-17, 50 ng/mL; TNF-α, 1 ng/mL, R&D Systems; IFN-γ, 1 ng/mL, Biolegend; or their combination), or towards CCL5 (60 and 200 ng/mL, R&D Systems) and/or CCL20 (300 and 1000 ng/mL, R&D Systems). Depletion of CCL5 and/or CCL20 from Th17-derived supernatants was obtained by specific capture antibodies (R&D Systems). Cell migration was quantified by flow cytometry.
+ Open protocol
+ Expand
8

Isolation and Culture of Bone Marrow Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
To harvest bone marrow cells, femurs and tibiae from WT BL6 mice were flushed under sterile conditions. Cells were filtered through a 40 μm mesh and cultured in Teflon bags (PermaLife PL-30) for 6 d in DMEM supplemented with 5% FBS, or 5% serum derived from either LF/HF mice or lean/obese humans. Recombinant proteins (CCL25, CD40L, GM-CSF, IGFBP2, IL5, IL6, MMP3, MMP9, 100 ng ml−1 for all; R&D Systems) or neutralization antibodies (IgG versus anti-GM-CSF, 0.1 μg ml−1) were added as indicated. Treatment media were changed every other day. After 6 d, flow cytometry was performed using antibodies against murine CD45, CD11b and Gr1 (see Supplementary Table 3).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!